Posted inMarket PYC Therapeutics Q3 2026 Earnings Beat Expectations Driven by Strong Trial Data Discover how PYC Therapeutics surpassed Q3 2026 earnings per share estimates, fueled by positive clinical trial results and an upgraded outlook. Posted by Prasenjit Bhowmik September 23, 2026
